Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/2005
11/09/2005CN1226413C Trichina TS88 gene, their protein products and uses
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962903 Modified annexin proteins and methods for preventing thrombosis
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/08/2005US6962694 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
11/08/2005CA2153806C Detection and treatment of mutations in a cd40 ligand gene
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103088A1 A single-domain antibody strengthening fusion protein vh-ldp-ae
11/03/2005WO2005103087A1 Method for the purification of albumin conjugates
11/03/2005WO2005102038A2 Expression of polypeptides in rod outer segment membranes
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244921 Fluorescent protein variants and methods for making same
11/03/2005US20050244901 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005CA2564031A1 Method for the purification of albumin conjugates
11/02/2005EP1590436A2 Rat receptor tyrosine kinase, kdr
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1200563B1 Attenuated influenza virus useful as vaccine
11/02/2005EP1183355B1 T-bet compositions and methods of use thereof
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP0601135B1 Osteogenic proteins in the treatment of metabolic bone diseases
11/02/2005CN1690203A Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2005CN1690081A Heterozygous toxin attacking VEGFR2 positive cell and genes encoding same
11/02/2005CN1690080A Heterozygous toxin attacking VEGFR1 positive cell and genes encoding same
11/02/2005CN1225555C Human TOLL-like receptor proteins, related reagents and methods
11/02/2005CN1225481C Recombinant fusion resisting tumour attack and transfer
11/01/2005US6960659 immunoreactive antigenic epitopes from several genotypes of hepatitis C virus; vaccines
11/01/2005US6960652 Used to produce immunotoxins (ITs) and cytokines with a reduced ability to promote vascular leak syndrome (VLS)
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
10/2005
10/27/2005WO2005100568A1 Recombined dna, pasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/27/2005WO2005100406A1 Function proteins of high potency and low toxicity
10/27/2005WO2005099741A1 Remedy for motoneuron diseases
10/27/2005WO2005072045A3 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
10/27/2005WO2005068616A3 Immunokinases
10/27/2005US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238579 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1587843A2 Combinatorial libraries of monomer domains
10/26/2005EP0506757B2 A recombinant human factor viii derivative
10/26/2005CN1688607A Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
10/26/2005CN1688606A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
10/26/2005CN1688605A Novel immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes
10/26/2005CN1224627C Modified factor VIII
10/25/2005US6958236 Control of gene expression in plants
10/25/2005US6958152 Human phospholipase C delta 5
10/20/2005WO2005097987A1 Antiinfection vaccine antigen for mucosa-directional human papillomavirus group
10/20/2005WO2005097156A1 Remedy for neurodegenerative diseases
10/20/2005US20050233428 Method of affinity purifying proteins using modified bis-arsenical fluorescein
10/20/2005US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/20/2005US20050232932 Compositions and methods for dendritic cell-based immunotherapy
10/20/2005CA2563513A1 Remedy for neurodegenerative diseases
10/19/2005EP1586635A1 Fusion proteins with parts of immunoglobulins, their production and use
10/19/2005EP1586582A1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
10/19/2005EP1585546A2 Kim-1 antagonists and use to modulate immune system
10/19/2005EP1307482B1 Two coloured fluorimetric protease assay
10/19/2005EP1104482B1 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
10/19/2005CN1684975A Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/19/2005CN1684700A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
10/19/2005CN1683416A High efficiency low toxicity series functional protein
10/19/2005CN1683415A Transduction peptide-insecticidal crystal protein fased protein and its corresponding sequence and use
10/18/2005US6955899 comprises collagen-like domain; tissue remodeling
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955877 cell-free expression/fusion proteins; solid phase synthesis
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095456A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/12/2005EP1584685A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP1417237A4 Process for preparation of polypeptides of interest from fusion peolypeptides
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1681838A Nogo受体拮抗剂 Nogo receptor antagonist
10/12/2005CN1680451A Immune responses against HPV antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
10/12/2005CN1680450A Fusion protein, coding gene and use thereof
10/12/2005CN1680433A Recombinant N protein antigen and purification for transmissible gastroenteritis of swine
10/12/2005CN1222539C Human receptor proteins, related reagents and methods
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/06/2005WO2005093431A2 Methods for detecting calcium ion influx
10/06/2005US20050223430 Gntiii expression in plants
10/06/2005US20050222392 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
10/06/2005US20050222389 Method for preparing modified polypeptides
10/06/2005US20050222386 Biomolecule transduction motif sim-2-btm and the use thereof
10/06/2005US20050222385 Hybrid and tandem expression of neisserial proteins
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221428 Chimeric neuropeptide Y receptors
10/06/2005US20050221420 Nogo receptor homologues and their use
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 295